Australia's Vitrafy Life Sciences rises on partnership with IMV Technologies

Vitrafy Life Sciences

15/01/2026 24:31

** Shares of Vitrafy Life Sciences VFY.AX rise as much as 26.7% to A$1.66, logging their best intraday pct gain

** Stock hits its highest level since August 12

** The biomedical firm enters an agreement with IMV Technologies

** Co says partnership for merging co's cryopreservation technology with IMV’s farm animal market

** IMV specialises in products and services for artificial insemination, cryopreservation and reproductive management of domestic animals

** Stock lost 24.7% in 2025 and is up 18.4%, YTD

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))